Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Citric Acid → Florfenicol Flunixin
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Citric Acid | HCID 311 | — |
| 반응물 | Propylene Glycol | HCID 1030 | — |
| 반응물 | 1,3-Dioxolane-4-methanol | HCID 21618 | — |
| 반응물 | Flunixin Meglumine | HCID 39212 | — |
| 반응물 | Florfenicol | HCID 114811 | — |
| 용매 | N-methyl-2-pyrrolidone | HCID 13387 | — |
| 용매 | Dimethylacetamide | HCID 31374 | — |
| 생성물 | Florfenicol Flunixin | HCID 86602307 | — |
반응 단계
The NMP or dimethylacetamide, citric acid, propylene glycol, and approximately 90% of the PEG 300 or glycerol formal required for each formulation were charged to the compounding vessel and mixed well. The florfenicol and flunixin meglumine were added with mixing until all solids were dissolved. The volume was adjusted with the remaining PEG 300 or glycerol formal.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08044102B2 |
| 출처 데이터셋 | uspto-grants-2011_10 |
| ORD ID | ord-f33629d272154f038dc051a2ce161aaf |
| 출처 메모 | uspto-grants-2011_10 |